Oral health status and quality of life in female patients receiving low dose bone-modifying agents for cancer treatment-induced bone loss: a single-center exploratory study

IntroductionBreast cancer patients, undergoing low-dose bone-modifying agent (LD-BMA) therapy for cancer treatment-induced bone loss (CTIBL), represent an emerging category at risk of Medication-Related (MRONJ) low (<1%) but not absent. However, data on their oral health status and quality of lif...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Rodolfo Mauceri, Martina Coppini, Sara Maria Marchese, Nicola Mauceri, Rita Coniglio, Marco Nisi, Maria Elena Mauceri, Vittorio Fusco, Maria Rosaria Valerio, Giuseppina Campisi
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2025-10-01
Edice:	Frontiers in Oral Health
Témata:	osteonecrosis of the jaw ONJ MRONJ breast cancer cancer treatment-induced bone loss CTIBL
On-line přístup:	https://www.frontiersin.org/articles/10.3389/froh.2025.1683722/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!